Collagenase and Tyrosinase Inhibitory Compounds from Fish Gut Bacteria Ruegeria atlantica and Pseudoalteromonas neustonica

Ruegeria atlantica and Pseudoalteromonas neustonica are fish gut bacteria that have been isolated from the guts of Pagrus major and Acanthopagrus schlegelii, respectively. A total of 22 compounds (1–22) were isolated from these two bacteria; 16 compounds (1–16) from R. atalantica and 6 compounds (17...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:ACS omega 2024-08, Vol.9 (32), p.34259-34267
Hauptverfasser: Kim, Jonghwan, Hwang, Su Jung, Lee, Gyu Sung, Lee, Ju Ryeong, An, Hye In, Im, Hong Sik, Kim, Minji, Lee, Sang-Seob, Lee, Hyo-Jong, Kim, Chung Sub
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Ruegeria atlantica and Pseudoalteromonas neustonica are fish gut bacteria that have been isolated from the guts of Pagrus major and Acanthopagrus schlegelii, respectively. A total of 22 compounds (1–22) were isolated from these two bacteria; 16 compounds (1–16) from R. atalantica and 6 compounds (17–22) from P. neustonica. Their chemical structures were elucidated by spectroscopic and spectrometric data analysis and chemical synthesis. Compounds 11 and 13 showed strong collagenase inhibitory activity, with 31.91% and 36.43% at 20 μM, respectively, comparable to or surpassing that of the positive control epigallocatechin gallate (EGCG, 34.66%). Also, compounds 11 and 14 exhibited a mild tyrosinase inhibitory effect of 6.73% and 13.68%, respectively. All of the tested compounds displayed no significant antibacterial activity against Escherichia coli and Bacillus subtilis up to 100 μM. The collagenase- and tyrosinase-inhibitory compound 11, cyclo­(l-Pro-d-Leu), was found to be stable under heat (50 °C) and UV light (254 and 365 nm) for up to 6 days. These results indicate that compound 11 could be developed into a cosmeceutical with antiaging effects.
ISSN:2470-1343
2470-1343
DOI:10.1021/acsomega.3c09585